This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Modeling Impaired Judgement in Cocaine Abusers - 6

This study has been completed.
New York MDRU
Information provided by:
National Institute on Drug Abuse (NIDA) Identifier:
First received: April 18, 2001
Last updated: January 11, 2017
Last verified: June 1998
The purpose of this study is for the modeling of impaired judgement in cocaine abusers.

Condition Intervention Phase
Cocaine-Related Disorders Substance-Related Disorders Behavioral: Amantadine Phase 4

Study Type: Interventional
Study Design: Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Modeling Impaired Judgement in Cocaine Abusers

Resource links provided by NLM:

Further study details as provided by National Institute on Drug Abuse (NIDA):

Estimated Enrollment: 0
Study Start Date: March 1997
Detailed Description:
The objective of this study is to investigate recognition memory and appreciation of changing contingencies in relation to a response judgement.

Ages Eligible for Study:   18 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

(3 groups)Normal, healthy controls. Recent cocaine experience. Over 6 months since the last cocaine experience.

Exclusion Criteria:

Psychosis or mood disorder. History of seizure, head trauma

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00015236

United States, New York
New York MDRU
New York, New York, United States, 10010
Sponsors and Collaborators
National Institute on Drug Abuse (NIDA)
New York MDRU
Principal Investigator: John Rotrosen, M.D. New York MDRU
  More Information

NIDA Research Monograph Series 179, 1998 CPDD 98, 99. Identifier: NCT00015236     History of Changes
Other Study ID Numbers: NIDA-5-0013-6
Study First Received: April 18, 2001
Last Updated: January 11, 2017

Additional relevant MeSH terms:
Substance-Related Disorders
Cocaine-Related Disorders
Pathologic Processes
Chemically-Induced Disorders
Mental Disorders
Anesthetics, Local
Central Nervous System Depressants
Physiological Effects of Drugs
Sensory System Agents
Peripheral Nervous System Agents
Vasoconstrictor Agents
Dopamine Uptake Inhibitors
Neurotransmitter Uptake Inhibitors
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Dopamine Agents
Neurotransmitter Agents
Antiparkinson Agents
Anti-Dyskinesia Agents
Antiviral Agents
Anti-Infective Agents
Analgesics, Non-Narcotic
Analgesics processed this record on August 18, 2017